Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour

Trends in Parasitology

Volumn 25, Issue 9, 2009, Pages 423-431

  Wilson, R Alan ^a   Coulson, Patricia S ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLYSIS; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOMODULATION; REVIEW; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; ANTIGENS, HELMINTH; HOST-PARASITE INTERACTIONS; HUMANS; LARVA; MACACA MULATTA; MICE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES;

PRIMATES; RODENTIA; SCHISTOSOMA MANSONI;

EID: 69449105403     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2009.05.011     Document Type: Review

References (77)

1. Fulford A.J., et al. On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 105 (1992) 219-227
2. Dunne D.W., and Mountford A.P. Resistance to infection in humans and animal models. In: Mahmoud A.F.F. (Ed). Schistosomiasis (2001), Imperial College Press 133-212
3. Fitzsimmons C.M., et al. Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure. Int Arch Allergy Immunol 142 (2007) 40-50
4. Braschi S., et al. The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 6 (2006) 1471-1482
5. Walter K., et al. Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens. J Immunol 177 (2006) 5490-5498
6. Curwen R.S., et al. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasitol 138 (2004) 57-66
7. Skelly P.J., and Wilson R.A. Making sense of the schistosome surface. Adv Parasitol 63 (2006) 185-284
8. McLaren D.J., and Terry R.J. The protective role of acquired host antigens during schistosome maturation. Parasite Immunol 4 (1982) 129-148
9. Braschi S., et al. Proteomic analysis of the schistosome tegument and its surface membranes. Mem Inst Oswaldo Cruz 101 Suppl 1 (2006) 205-212
10. Braschi S., and Wilson R.A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5 (2006) 347-356
11. Mkoji G.M., et al. Antioxidant systems in Schistosoma mansoni: evidence for their role in protection of the adult worms against oxidant killing. Int J Parasitol 18 (1988) 667-673
12. Nare B., et al. Schistosoma mansoni: levels of antioxidants and resistance to oxidants increase during development. Exp Parasitol 70 (1990) 389-397
13. Mei H., and LoVerde P.T. Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes. Exp Parasitol 86 (1997) 69-78
14. LoVerde P.T. Do antioxidants play a role in schistosome host-parasite interactions?. Parasitol Today 14 (1998) 284-289
15. Sayed A.A., and Williams D.L. Biochemical characterization of 2-Cys peroxiredoxins from Schistosoma mansoni. J Biol Chem 279 (2004) 26159-26166
16. Kuntz A.N., et al. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med 4 (2007) e206
17. Imai H., and Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 34 (2003) 145-169
18. Mountford A.P., and Trottein F. Schistosomes in the skin: a balance between immune priming and regulation. Trends Parasitol 20 (2004) 221-226
19. Curwen R.S., et al. Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry. Mol Cell Proteomics 5 (2006) 835-844
20. Valle C., et al. Stage-specific expression of a Schistosoma mansoni polypeptide similar to the vertebrate regulatory protein stathmin. J Biol Chem 274 (1999) 33869-33874
21. Rao K.V., and Ramaswamy K. Cloning and expression of a gene encoding Sm16, an anti-inflammatory protein from Schistosoma mansoni. Mol Biochem Parasitol 108 (2000) 101-108
22. Holmfeldt P., et al. The Schistosoma mansoni protein Sm16/SmSLP/SmSPO-1 is a membrane-binding protein that lacks the proposed microtubule-regulatory activity. Mol Biochem Parasitol 156 (2007) 225-234
23. Brannstrom K., et al. The Schistosoma mansoni protein Sm16/SmSLP/SmSPO-1 assembles into a nine-subunit oligomer with potential to inhibit Toll-like receptor signaling. Infect Immun 77 (2009) 1144-1154
24. Chalmers I.W., et al. Developmentally regulated expression, alternative splicing and distinct sub-groupings in members of the Schistosoma mansoni venom allergen-like (SmVAL) gene family. BMC Genomics 9 (2008) 89
25. Asojo O.A., et al. X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite, Necator americanus, and a vaccine antigen for human hookworm infection. J Mol Biol 346 (2005) 801-814
26. Dillon G.P., et al. Microarray analysis identifies genes preferentially expressed in the lung schistosomulum of Schistosoma mansoni. Int J Parasitol 36 (2006) 1-8
27. Lorenzo C., et al. Echinococcus granulosus antigen 5 is closely related to proteases of the trypsin family. Biochem J 369 (2003) 191-198
28. Dillon G.P., et al. Patterns of gene expression in schistosomes: localization by whole mount in situ hybridization. Parasitology 134 (2007) 1589-1597
29. Fry B.G., et al. Tentacles of venom: toxic protein convergence in the Kingdom Animalia. J Mol Evol 68 (2009) 311-321
30. Keating J.H., et al. No overt cellular inflammation around intravascular schistosomes in vivo. J Parasitol 92 (2006) 1365-1369
31. Pearce E.J., et al. Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor. J Immunol 144 (1990) 2751-2756
32. Wu X., et al. Membrane protein Crry maintains homeostasis of the complement system. J Immunol 181 (2008) 2732-2740
33. Parizade M., et al. Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59. J Exp Med 179 (1994) 1625-1636
34. Deng J., et al. Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin. Infect Immun 71 (2003) 6402-6410
35. Fiscella M., et al. TIP, a T-cell factor identified using high-throughput screening increases survival in a graft-versus-host disease model. Nat Biotechnol 21 (2003) 302-307
36. Wilson R.A., et al. 'Oming in on schistosomes: prospects and limitations for post-genomics. Trends Parasitol 23 (2007) 14-20
37. Coulson P.S. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine?. Adv Parasitol 39 (1997) 271-336
38. Kariuki T.M., et al. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun 72 (2004) 5526-5529
39. Minard P., et al. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg 27 (1978) 76-86
40. Kariuki T.M., et al. Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine. Infect Immun 74 (2006) 3979-3986
41. Jang-Lee J., et al. Glycomics analysis of Schistosoma mansoni egg and cercarial secretions. Mol Cell Proteomics 6 (2007) 1485-1499
42. Eberl M., et al. Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun 69 (2001) 5352-5362
43. Eberl M., et al. Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive?. J Infect Dis 183 (2001) 1238-1247
44. Kariuki T.M., et al. Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes. Parasite Immunol 30 (2008) 554-562
45. Wilson R.A., et al. Elimination of Schistosoma mansoni adult worms by rhesus macaques: basis for a therapeutic vaccine?. PLoS Negl Trop Dis 2 (2008) e290
46. Mangold B.L., and Dean D.A. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J Immunol 136 (1986) 2644-2648
47. Cardoso F.C., et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2 (2008) e308
48. Yole D.S., et al. Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine. Parasitology 112 Pt 1 (1996) 37-46
49. Cutts L., and Wilson R.A. Elimination of a primary schistosome infection from rats coincides with elevated IgE titres and mast cell degranulation. Parasite Immunol 19 (1997) 91-102
50. Miller H.R., et al. Hepatic recruitment of mast cells occurs in rats but not mice infected with Schistosoma mansoni. Parasite Immunol 16 (1994) 145-155
51. Imbert-Establet D., et al. Schistosome-induced portacaval haemodynamic changes in Rattus rattus are associated with translocation of adult worms to the lungs. Parasitology 116 (1998) 237-241
52. Tryphonas H., et al. Animal models to detect allergenicity to foods and genetically modified products: workshop summary. Environ Health Perspect 111 (2003) 221-222
53. Hamdan F.F., et al. A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine. Mol Biochem Parasitol 119 (2002) 75-86
54. Phillips S.M., et al. The cellular and humoral immune response to Schistosoma mansoni infections in inbred rats. II. Mechanisms during reexposure. Cell Immunol 28 (1977) 75-89
55. Smithers S.R., and Terry R.J. Naturally acquired resistance to experimental infections of Schistosoma mansoni in the rhesus monkey (Macaca mulatta). Parasitology 55 (1965) 701-710
56. Krautz-Peterson G., et al. Imaging schistosomes in vivo. Faseb J (2009)
57. Giuliani M.M., et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 103 (2006) 10834-10839
58. Moser K., et al. Long-lived plasma cells in immunity and immunopathology. Immunol Lett 103 (2006) 83-85
59. Lightowlers M.W. Cestode vaccines: origins, current status and future prospects. Parasitology 133 Suppl (2006) S27-42
60. Knudsen G.M., et al. Proteomic analysis of Schistosoma mansoni cercarial secretions. Mol Cell Proteomics 4 (2005) 1862-1875
61. Crabtree J.E., and Wilson R.A. Schistosoma mansoni: an ultrastructural examination of skin migration in the hamster cheek pouch. Parasitology 91 Pt 1 (1985) 111-120
62. Wilson R.A., and Lawson J.R. An examination of the skin phase of schistosome migration using a hamster cheek pouch preparation. Parasitology 80 (1980) 257-266
63. Lawson J.R., and Wilson R.A. Metabolic changes associated with the migration of the schistosomulum of Schistosoma mansoni in the mammal host. Parasitology 81 (1980) 325-336
64. Mangold B.L., et al. Site requirements and kinetics of immune-dependent elimination of intravascularly administered lung stage schistosomula in mice immunized with highly irradiated cercariae of Schistosoma mansoni. Am J Trop Med Hyg 35 (1986) 332-344
65. Wilson R.A., and Coulson P.S. Schistosoma mansoni: dynamics of migration through the vascular system of the mouse. Parasitology 92 Pt 1 (1986) 83-100
66. Wilson, R.A. (2009) The saga of schistosome migration and attrition. Parasitology, in press
67. Fallon P.G., et al. Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoni. J Infect Dis 187 (2003) 939-945
68. Kusel J.R., et al. The schistosome in the mammalian host: understanding the mechanisms of adaptation. Parasitology 134 (2007) 1477-1526
69. Morris G.P. Fine structure of the gut epithelium of Schistosoma mansoni. Experientia 24 (1968) 480-482
70. Wilson R.A., and Barnes P.E. The tegument of Schistosoma mansoni: observations on the formation, structure and composition of cytoplasmic inclusions in relation to tegument function. Parasitology 68 (1974) 239-258
71. Davis R.E., et al. Tandemly repeated exons encode 81-base repeats in multiple, developmentally regulated Schistosoma mansoni transcripts. Mol Cell Biol 8 (1988) 4745-4755
72. Dillon G.P., et al. Altered patterns of gene expression underlying the enhanced immunogenicity of radiation-attenuated schistosomes. PLoS Negl Trop Dis 2 (2008) e240
73. Wilson R.A., et al. Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice?. Immunol Lett 65 (1999) 117-123
74. Street M., et al. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol 163 (1999) 4489-4494
75. Jankovic D., et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J Immunol 162 (1999) 345-351
76. Berriman, M. and 56 others. (2009) The Genome of the blood fluke Schistosoma mansoni. Nature 460, 352-358
77. Luke T.C., and Hoffman S.L. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol 206 (2003) 3803-3808